In addition, PBE treatment resulted in significantly reduced levels of serum DHT compared to that of BPH animals; this was accompanied by declines in the PCNA and Ki‐67 expressions on the prostate. The gene discussed is MKI67; the disease is benign prostatic hyperplasia.